[go: up one dir, main page]

TR200703568A1 - Valsartan formülasyonları - Google Patents

Valsartan formülasyonları

Info

Publication number
TR200703568A1
TR200703568A1 TR2007/03568A TR200703568A TR200703568A1 TR 200703568 A1 TR200703568 A1 TR 200703568A1 TR 2007/03568 A TR2007/03568 A TR 2007/03568A TR 200703568 A TR200703568 A TR 200703568A TR 200703568 A1 TR200703568 A1 TR 200703568A1
Authority
TR
Turkey
Prior art keywords
valsartan
formulations
valsartan formulations
active agent
microcrystalline cellulose
Prior art date
Application number
TR2007/03568A
Other languages
English (en)
Inventor
��Fter �M�T
Al� Turp Hasan
T�Rkyilmaz Al�
Original Assignee
Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38982518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200703568(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� filed Critical Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�
Priority to TR2007/03568A priority Critical patent/TR200703568A1/tr
Priority to AT08104077T priority patent/ATE451097T1/de
Priority to EP08104077A priority patent/EP1994926B9/en
Priority to PL08104077T priority patent/PL1994926T3/pl
Priority to ES08104077T priority patent/ES2337848T3/es
Priority to PT08104077T priority patent/PT1994926E/pt
Priority to US12/126,353 priority patent/US20080293789A1/en
Priority to SI200830014T priority patent/SI1994926T1/sl
Priority to DK08104077.6T priority patent/DK1994926T3/da
Priority to DE602008000367T priority patent/DE602008000367D1/de
Publication of TR200703568A1 publication Critical patent/TR200703568A1/tr
Priority to CY20101100204T priority patent/CY1109865T1/el
Priority to HR20100120T priority patent/HRP20100120T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş, tablet şeklinde farmasötik bir formülasyon olup, etken madde olarak valsartan, prejelatinize nişasta ve mikrokristalin selüloz içermektedir.
TR2007/03568A 2007-05-24 2007-05-24 Valsartan formülasyonları TR200703568A1 (tr)

Priority Applications (12)

Application Number Priority Date Filing Date Title
TR2007/03568A TR200703568A1 (tr) 2007-05-24 2007-05-24 Valsartan formülasyonları
DE602008000367T DE602008000367D1 (de) 2007-05-24 2008-05-23 Valsartanformulierungen
ES08104077T ES2337848T3 (es) 2007-05-24 2008-05-23 Formulaciones de valsartan.
EP08104077A EP1994926B9 (en) 2007-05-24 2008-05-23 Valsartan formulations
PL08104077T PL1994926T3 (pl) 2007-05-24 2008-05-23 Preparaty walsartanu
AT08104077T ATE451097T1 (de) 2007-05-24 2008-05-23 Valsartanformulierungen
PT08104077T PT1994926E (pt) 2007-05-24 2008-05-23 Formulações de valsartan
US12/126,353 US20080293789A1 (en) 2007-05-24 2008-05-23 Valsartan formulations
SI200830014T SI1994926T1 (sl) 2007-05-24 2008-05-23 Farmacevtske oblike valsartana
DK08104077.6T DK1994926T3 (da) 2007-05-24 2008-05-23 Valsartanformuleringer
CY20101100204T CY1109865T1 (el) 2007-05-24 2010-03-01 Συνθεσεις βαλσαρτανης
HR20100120T HRP20100120T1 (hr) 2007-05-24 2010-03-04 Formulacije s valsartanom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2007/03568A TR200703568A1 (tr) 2007-05-24 2007-05-24 Valsartan formülasyonları

Publications (1)

Publication Number Publication Date
TR200703568A1 true TR200703568A1 (tr) 2008-07-21

Family

ID=38982518

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2007/03568A TR200703568A1 (tr) 2007-05-24 2007-05-24 Valsartan formülasyonları

Country Status (12)

Country Link
US (1) US20080293789A1 (tr)
EP (1) EP1994926B9 (tr)
AT (1) ATE451097T1 (tr)
CY (1) CY1109865T1 (tr)
DE (1) DE602008000367D1 (tr)
DK (1) DK1994926T3 (tr)
ES (1) ES2337848T3 (tr)
HR (1) HRP20100120T1 (tr)
PL (1) PL1994926T3 (tr)
PT (1) PT1994926E (tr)
SI (1) SI1994926T1 (tr)
TR (1) TR200703568A1 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010104485A2 (en) * 2009-03-11 2010-09-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations
TR201005419A2 (tr) * 2010-07-05 2012-01-23 B�Lg�� Mahmut Valsartan içeren farmasötik bileşim.
EP2990029A1 (en) * 2014-08-29 2016-03-02 Sandoz Ag Pharmaceutical compositions comprising Canagliflozin
CN105769788A (zh) * 2016-03-11 2016-07-20 江苏中邦制药有限公司 一种缬沙坦片剂及制备方法
CN105816419A (zh) * 2016-05-26 2016-08-03 陈欣怡 一种包含缬沙坦的药物组合物
CN112807286A (zh) * 2021-01-20 2021-05-18 海南皇隆制药股份有限公司 一种缬沙坦分散片制备方法和缬沙坦分散片
CN112826806A (zh) * 2021-01-20 2021-05-25 海南皇隆制药股份有限公司 一种缬沙坦片制备方法和缬沙坦片
WO2025140517A1 (zh) * 2023-12-28 2025-07-03 和记黄埔医药（上海）有限公司 一种药物组合物及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066961A1 (en) * 2004-12-24 2006-06-29 Krka, D.D., Novo Mesto Solid pharmaceutical composition comprising valsartan
WO2007022113A2 (en) * 2005-08-17 2007-02-22 Novartis Ag Solid dosage forms of valsartan and amlodipine and method of making the same
WO2007026261A2 (en) * 2005-05-18 2007-03-08 Combino Pharm, S.L. Formulations containing losartan and/or its salts
WO2007049292A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Pharmaceutical formulation of losartan
WO2007049291A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Novel solid dosage forms of valsartan and rochlorothiazide
WO2007052307A2 (en) * 2005-10-31 2007-05-10 Lupin Limited Stable solid oral dosage forms of valsartan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0511767A1 (en) 1991-04-29 1992-11-04 Merck & Co. Inc. Tablets containing compound DUP753
DE4408497A1 (de) 1994-03-14 1995-09-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JPH09510225A (ja) 1994-03-17 1997-10-14 チバ−ガイギー アクチェンゲゼルシャフト バルサルタンを用いる糖尿病性ネフロパシーの治療
TW442301B (en) 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DK1588706T3 (da) 1998-12-23 2012-01-16 Novartis Ag Valsartantablet
US20020132839A1 (en) * 2000-06-22 2002-09-19 Ganter Sabina Maria Tablet formulations comprising valsartan
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
PL382044A1 (pl) 2003-11-03 2007-08-06 Zentiva, A.S. Preparat zawierający walsartan

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066961A1 (en) * 2004-12-24 2006-06-29 Krka, D.D., Novo Mesto Solid pharmaceutical composition comprising valsartan
WO2007026261A2 (en) * 2005-05-18 2007-03-08 Combino Pharm, S.L. Formulations containing losartan and/or its salts
WO2007022113A2 (en) * 2005-08-17 2007-02-22 Novartis Ag Solid dosage forms of valsartan and amlodipine and method of making the same
WO2007049292A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Pharmaceutical formulation of losartan
WO2007049291A1 (en) * 2005-10-27 2007-05-03 Lupin Limited Novel solid dosage forms of valsartan and rochlorothiazide
WO2007052307A2 (en) * 2005-10-31 2007-05-10 Lupin Limited Stable solid oral dosage forms of valsartan

Also Published As

Publication number Publication date
US20080293789A1 (en) 2008-11-27
SI1994926T1 (sl) 2010-04-30
ES2337848T3 (es) 2010-04-29
EP1994926B9 (en) 2010-05-19
DK1994926T3 (da) 2010-04-26
PT1994926E (pt) 2010-03-16
PL1994926T3 (pl) 2010-05-31
ATE451097T1 (de) 2009-12-15
EP1994926A1 (en) 2008-11-26
DE602008000367D1 (de) 2010-01-21
HRP20100120T1 (hr) 2010-04-30
EP1994926B1 (en) 2009-12-09
CY1109865T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
NO20083630L (no) Nye pyridinderivater
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
NO20091395L (no) Nye tiofenderivater
NO20082793L (no) Nye tiofenderivater
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MY153921A (en) Aminopyrazole derivatives
MY154909A (en) Novel thiophene derivatives
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20090295L (no) Substituerte heteroarylderivater
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX342440B (es) Derivados fluorados de aminotriazol.
MX341200B (es) Composicion farmaceutica de disolucion rapida.
SI2242740T1 (sl) SF5-derivati kot PAR1 inhibitorji, njihova priprava in uporaba kot zdravila
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
JO3112B1 (ar) تركيبة دوائية سريعة التحلل
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
NI201100227A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2011037976A3 (en) Pramipexole pharmaceutical formulations
MX2009007764A (es) Formulacion de nevirapina de liberacion prolongada.
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
WO2010104485A3 (en) Valsartan formulations